Art. 98 Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 13×
1.

The marketing authorization holder shall establish, within his undertaking, a scientific service in charge of information about the medicinal products which he places on the market.

2.

The marketing authorization holder shall:

keep available for, or communicate to, the authorities or bodies responsible for monitoring advertising of medicinal products, a sample of all advertisements emanating from his undertaking together with a statement indicating the persons to whom it is addressed, the method of dissemination and the date of first dissemination,

ensure that advertising of medicinal products by his undertaking conforms to the requirements of this Title,

verify that medical sales representatives employed by his undertaking have been adequately trained and fulfill the obligations imposed upon them by Article 93(2) and (3),

supply the authorities or bodies responsible for monitoring advertising of medicinal products with the information and assistance they require to carry out their responsibilities,

ensure that the decisions taken by the authorities or bodies responsible for monitoring advertising of medicinal products are immediately and fully complied with.

3.

The Member States shall not prohibit the co-promotion of a medicinal product by the holder of the marketing authorisation and one or more companies nominated by him.

The 10 that are cited most themselves, of 13.

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Third Chamber) of 1 October 2020. A v Daniel B and Others.Decision

    Title VIII, entitled ‘Advertising’, and Title VIIIa, entitled ‘Information and advertising’ of Directive 2001/83 contain, respectively, Articles 86 to 88 and Articles 88a to 100 of that directive.

    1 Oct 2020 · 62018CJ0649

  • Judgment of the Court (Third Chamber) of 11 June 2020. ratiopharm GmbH v Novartis Consumer Health GmbH.Decision

    Title VIIIa of Directive 2001/83, entitled ‘Information and Advertising’, comprises Articles 88a to 100 thereof.

    11 Jun 2020 · 62018CJ0786

  • Judgment of the Court (Third Chamber) of 5 May 2011. Novo Nordisk AS v Ravimiamet.Decision

    It is observed, first of all, that, as the Advocate General stated in point 30 of his Opinion, a systematic analysis of Titles VIII and VIIIa of Directive 2001/83 reveals four groups of rules. Under Title VIII of that directive, entitled …

    5 May 2011 · 62009CJ0249

  • Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…82Law

    … силата на настоящия регламент лекарствени продукти се прилага член 98, параграф 3 от Директива 2001/83/ЕО. 3. Без да се засяга уникалното …

  • Judgment of the Court (Fourth Chamber) of 22 April 2010. The Queen, on the application of Association of the British Pharmaceutical IndustryDecision

    Title VIII of the directive, entitled ‘Advertising’, contains Articles 86 to 88 thereof, whereas Title VIIIa of the directive, entitled ‘Information and advertising’, contains Articles 88a to 100.

    22 Apr 2010 · 62009CJ0062

  • Judgment of the Court (Grand Chamber) of 22 December 2022. SIA 'EUROAPTIEKA' v Ministru kabinets.Decision

    Title VIII of that directive, entitled ‘Advertising’, and Title VIIIa thereof, entitled ‘Information and advertising’ contain, respectively, Articles 86 to 88 and Articles 88a to 100 of that directive.

    22 Dec 2022 · 62020CJ0530

  • Opinion of Mr Advocate General Ruiz-Jarabo Colomer delivered on 18 November 2008. Criminal proceedings against Frede Damgaard.Decision

    Nor do I agree with the Polish Government’s submission that Article 98(3) of Directive 2001/83, in providing that the Member States may not prohibit the co-promotion of a medicinal product by the holder of the marketing authorisation and …

    18 Nov 2008 · 62007CC0421

  • Opinion of Advocate General Szpunar delivered on 9 June 2022. SIA 'EUROAPTIEKA' v Ministru kabinets.Decision

    I delivered an initial Opinion in this case on 9 December 2021, following which the oral part of the procedure was closed.

    9 Jun 2022 · 62020CC0530(01)

  • Opinion of Mr Advocate General Jääskinen delivered on 19 October 2010. Novo Nordisk AS v Ravimiamet.Decision

    A systematic analysis of Titles VIII and VIIIa of Directive 2001/83 reveals four groups of rules. Articles 86 and 87 of Directive 2001/83 contain general principles relating to all advertising, whereas the detailed rules on advertising to …

    19 Oct 2010 · 62009CC0249